E.N. Efanova1,2, L.L. Katanakhova1,3, O.I. Samoylova3, E.V. Pavlova2, I.V. Ulitina2,
M.V. Kramar’2, A.V. Soltys1
1Surgut State University, Surgut, Russian Federation
2Surgut Clinical Dermatovenerological Dispensary, Surgut, Russian Federation
3Surgut Regional Clinical Hospital, Surgut, Russian Federation
This paper addresses the etiology, epidemiology, clinical manifestations, diagnostics and treatment for larva migrans. Larva migrans occurs most commonly in tropical areas, in particular, in the Caribbean countries, Africa, South America, and Southeast Asia. Published data demonstrate the increasing number of the imported larva migrans cases in Russia. However, no clear diagnostic benchmarks are still developed. Larva migrans is accounted for by the cutaneous and/or visceral migration of the larvae of the helminths of cats and dogs which are unusual for humans and never develop in adults capable of reproduction. Clinically, the primary lesion is a 2–3-mm width erythematous serpiginous eruption filled with serous fluid. The number of eruptions complies with the number of larvae. Anti-helminthic drugs, i.e., mebendazole, thiabendazole, and albendazole, are recommended for larva migrans. The paper describes multiple cutaneous eruptions caused by larva migrans in a woman living in the northern region of the country. The authors highlight that the diagnosis was challenging. The early diagnosis and prompt treatment for helminthiases associated with cutaneous eruptions prevent gastrointestinal and other dangerous complications.
Keywords: larva migrans, migrating worm, cutaneous larva migrans, ancylostomiasis, helminths, mebendazole.
For citation: Efanova E.N., Katanakhova L.L., Samoylova O.I. et al. Multiple cutaneous eruptions in larva migrans: case study. Russian Medical Inquiry. 2020;4(10):647–651. DOI: 10.32364/2587-6821-2020-4-10-647-651.
About the authors:
Elena N. Efanova — Cand. of Sci. (Med.), associate professor of the Department of Multidisciplinary Clinical Training, Surgut State University, 1, Lenin av., Surgut, 628412, Russian Federation; ORCID iD 0000-0003-1355-3125.
Lyudmila L. Katanakhova — Cand. of Sci. (Med.), associate professor of the Department of Children’s Diseases, Surgut State University, 1, Lenin av., Surgut, 628412, Russian Federation; ORCID iD 0000-0002-3959-8391.
Olga I. Samoilova — Head of the Pediatric Infectious Department No. 2, Surgut Regional Clinical Hospital, 24/2, Energetikov str., Surgut, 628408, Russian Federation; ORCID iD 0000-0002-5449-0442.
Evgeniya V. Pavlova — Head of the Outpatient Polyclinic Department, Surgut Clinical Dermatovenerological Dispensary, 70, Beregovaya str., Surgut, 628403, Russian Federation; ORCID iD 0000-0001-7276-8412.
Irina V. Ulitina — Head Doctor, Surgut Clinical Dermatovenerological Dispensary, 70, Beregovaya str., Surgut, 628403, Russian Federation; ORCID iD 0000-0001-9873-1378.
Marina V. Kramar’ — Deputy Head Doctor for Medical Work, Surgut Clinical Dermatovenerological Dispensary, 70, Beregovaya str., Surgut, 628403, Russian Federation; ORCID iD 0000-0002-0155-1483.
Anastasiya V. Soltys — student of the 5th course of the Medical Institute, Surgut State University, 1, Lenin av., Surgut, 628412, Russian Federation; ORCID iD 0000-0002-0722-0802.
Contact information: Elena N. Efanova, e-mail: el.efanova2011@yandex.ru. Financial Disclosure: no authors have a financial or property interest in any material or method mentioned. There is no conflict of interests. Received 29.04.2020, revised 25.05.2020, accepted 11.06.2020.
